- VernacularTitle:4种肾素-血管紧张素系统调节剂对人白血病HEL细胞增殖的影响
- Author:
Yi-Zhi XU
1
;
Yun WANG
2
;
Dai-Ying HE
1
;
Liang ZHANG
3
Author Information
- Publication Type:Journal Article
- From: Journal of Experimental Hematology 2018;26(1):42-46
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo investigate the effects of 4 renin-angiotensin system's(RAS) regulators (losartan, telmisartan, aliskiren and angiotenisin) on the human leukemia HEL cell growth.
METHODSThe HEL cells were treated with losartan, telmisartan, aliskiren and Angiotensin-(1-7) (Ang-(1-7)) for 12 days, respectively. The cell proliferation was measured by CCK-8 kit, the cell cycle and apoptosis were measured by flow cytometry.
RESULTSThe 10mol/L Ang-(1-7) markedly inhibited the growth of HEL cells, blocked cells at G/Gphase and markedly increased the late apoptotic cells (P< 0.001). The 10mol/L losartan and telmisartan, 10mol/L aliskiren had no effects on the proliferation, cell cycle and apoptosis of HEL cells (P>0.05).
CONCLUSIONAng-(1-7), one of renin-angiotensin system's regulators, can inhibit the growth of HEL cells and promote the cell apoptosis. Ang-(1-7) may be one potential therapeutic drug for polycythemia vera with JAK2 mutation.

